MA27388A1 - Vaccin pour des infections du systeme respiratoire et du systeme reproducteur chez les bovins - Google Patents
Vaccin pour des infections du systeme respiratoire et du systeme reproducteur chez les bovinsInfo
- Publication number
- MA27388A1 MA27388A1 MA28121A MA28121A MA27388A1 MA 27388 A1 MA27388 A1 MA 27388A1 MA 28121 A MA28121 A MA 28121A MA 28121 A MA28121 A MA 28121A MA 27388 A1 MA27388 A1 MA 27388A1
- Authority
- MA
- Morocco
- Prior art keywords
- leptospira
- vaccine
- virus
- bovine
- cattle
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 210000004994 reproductive system Anatomy 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 210000002345 respiratory system Anatomy 0.000 title 1
- 241000589902 Leptospira Species 0.000 abstract 3
- 241000701083 Bovine alphaherpesvirus 1 Species 0.000 abstract 2
- 241000711895 Bovine orthopneumovirus Species 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 abstract 1
- 241000589874 Campylobacter fetus Species 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 241001550390 Leptospira interrogans serovar Canicola Species 0.000 abstract 1
- 241001518163 Leptospira interrogans serovar Hardjo-bovis Species 0.000 abstract 1
- 241001518154 Leptospira kirschneri serovar Grippotyphosa Species 0.000 abstract 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
- PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Toxicology (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Vaccin pour des infections du système respiratoire et du système reproducteur chez les bovins La présente invention concerne des vaccins combinés et méthodes pour le traitement ou la prévention de maladies ou d'affections, chez un animal, provoquées par une infection par le virus de la diarrhée virale bovine (BVDV) de types 1 et 2, le virus d'herpès bovin de type 1 (BHV-1), le virus syncytial respiratoire bovin 5 (BRSV), le virus parainfluenza (P13), Campylobacter fétus, Leptospira canicola, Leptospira grippotyphosa, Leptospira hardj-prajitno, Leptospira icterohaemmorrhagiae, Leptospira hardjo-bovis et Leptospira pomona par administration à l'animal d'une quantité efficace d'un vaccin combiné. Le vaccin combiné peut être une préparation vivante, inactivée ou modifiée, de cellules entières ou partielles.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40596902P | 2002-08-26 | 2002-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27388A1 true MA27388A1 (fr) | 2005-06-01 |
Family
ID=31946951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28121A MA27388A1 (fr) | 2002-08-26 | 2005-02-25 | Vaccin pour des infections du systeme respiratoire et du systeme reproducteur chez les bovins |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US20040081666A1 (fr) |
| EP (2) | EP1536830A1 (fr) |
| JP (4) | JP2006501237A (fr) |
| KR (2) | KR20050062542A (fr) |
| CN (1) | CN1315534C (fr) |
| AP (1) | AP2005003238A0 (fr) |
| AR (1) | AR041047A1 (fr) |
| AT (1) | ATE533506T1 (fr) |
| AU (2) | AU2003263390B2 (fr) |
| BR (1) | BR0313806A (fr) |
| CA (1) | CA2496750C (fr) |
| EA (1) | EA011578B1 (fr) |
| GT (1) | GT200300180A (fr) |
| HR (2) | HRP20090271A2 (fr) |
| IS (1) | IS7672A (fr) |
| MA (1) | MA27388A1 (fr) |
| ME (1) | ME00810B (fr) |
| MX (1) | MXPA05002255A (fr) |
| NO (1) | NO20050603L (fr) |
| NZ (2) | NZ538394A (fr) |
| OA (1) | OA12915A (fr) |
| PA (1) | PA8581101A1 (fr) |
| PE (1) | PE20040420A1 (fr) |
| PL (1) | PL216541B1 (fr) |
| RS (1) | RS20050177A (fr) |
| TN (1) | TNSN05059A1 (fr) |
| TW (1) | TWI272105B (fr) |
| UA (1) | UA94689C2 (fr) |
| UY (1) | UY27948A1 (fr) |
| WO (1) | WO2004017990A1 (fr) |
| ZA (1) | ZA200501171B (fr) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| JP2006501237A (ja) * | 2002-08-26 | 2006-01-12 | ファイザー・プロダクツ・インク | 家畜の呼吸系と生殖系の感染症に対するワクチン |
| US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
| US7563449B2 (en) * | 2003-04-21 | 2009-07-21 | Pfizer Inc, | Methods for reducing cattle reproductive diseases |
| US7361357B2 (en) | 2003-07-29 | 2008-04-22 | Pfizer Inc. | Safe mutant viral vaccines |
| MXPA06006947A (es) * | 2003-12-17 | 2007-01-26 | Wyeth Corp | Metodos para producir virus de almacenamiento estable y composiciones inmunogenicas de estos. |
| DK1742659T3 (da) * | 2004-04-05 | 2013-06-03 | Zoetis P Llc | Mikrofluidiserede olie-i-vand-emulsioner og vaccinesammensætninger |
| US7572455B2 (en) * | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
| US20090068223A1 (en) * | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| WO2008032158A2 (fr) | 2006-09-11 | 2008-03-20 | Pfizer Products Inc. | Bactérines thermotraitées et vaccins en émulsion préparés à partir de telles bactérines thermotraitées |
| WO2008036747A2 (fr) * | 2006-09-21 | 2008-03-27 | Amarillo Biosciences, Inc. | Composition et procédé d'immunomodulation |
| US7803527B2 (en) * | 2007-10-31 | 2010-09-28 | Novartis Ag | Inactivated bovine herpes virus-1 and methods |
| CN101903041A (zh) * | 2007-12-21 | 2010-12-01 | 辉瑞大药厂 | 经热处理的菌苗,及由这些经热处理的菌苗制备的乳剂疫苗 |
| UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| CA2738664C (fr) | 2008-10-03 | 2017-10-31 | Novartis Ag | Compositions du virus de l'herpes bovin-1, vaccin et procede |
| US8846054B2 (en) * | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| RU2395299C1 (ru) * | 2009-03-31 | 2010-07-27 | Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") | Вакцина инактивированная комбинированная против инфекционного ринотрахеита, вирусной диареи, рота-, коронавирусной болезней и лептоспироза крупного рогатого скота |
| RU2395297C1 (ru) * | 2009-03-31 | 2010-07-27 | Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") | Вакцина инактивированная комбинированная против инфекционного ринотрахеита, вирусной диареи и лептоспироза крупного рогатого скота |
| PE20140576A1 (es) * | 2011-06-10 | 2014-05-24 | Novartis Ag | Vacunas bovinas y metodos |
| RU2522780C2 (ru) * | 2012-07-27 | 2014-07-20 | Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной санитарии, гигиены и экологии Российской академии сельскохозяйственных наук | Способ получения вакцины против инфекционного ринотрахеита крупного рогатого скота |
| US9314519B2 (en) | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
| US20140147475A1 (en) | 2012-11-29 | 2014-05-29 | Antonius Arnoldus Christiaan Jacobs | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida |
| US9480739B2 (en) | 2013-03-15 | 2016-11-01 | Intervet Inc. | Bovine virus vaccines that are liquid stable |
| US9393298B2 (en) | 2013-03-15 | 2016-07-19 | Intervet Inc. | Liquid stable bovine virus vaccines |
| MX357432B (es) | 2013-03-18 | 2018-07-09 | Intervet Int Bv | Vacuna para proteger a un rumiante contra la neumonia causada por mannheimia haemolytica. |
| AR097762A1 (es) | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
| AR099470A1 (es) | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
| TWI670085B (zh) | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
| CA3010977A1 (fr) | 2016-01-11 | 2017-07-20 | Zoetis Services Llc | Nouvelles compositions vaccinales a protection croisee pour le virus de la diarrhee epidemique porcine |
| US11013798B2 (en) | 2016-03-21 | 2021-05-25 | South Dakota Board Of Regents | Orf virus-based platform for vaccine delivery |
| MX2019003947A (es) | 2016-10-05 | 2019-06-10 | Zoetis Services Llc | Metodos de liofilizacion que proporcionan protozoos deshidratados de forma estable para uso como potentes vacunas vivas. |
| RU2643335C1 (ru) * | 2016-11-14 | 2018-01-31 | Федеральное государственное бюджетное образовательное учреждение высшего образования Санкт-Петербургская государственная академия ветеринарной медицины (ФГБОУ ВПО СПбГ АВМ) | Инактивированная бивалентная гидроокись алюминиевая вакцина против кампилобактериоза собак |
| GB201703529D0 (en) | 2017-03-06 | 2017-04-19 | Cambridge Entpr Ltd | Vaccine composition |
| CN110317749B (zh) * | 2019-06-19 | 2021-01-22 | 山东省农业科学院奶牛研究中心 | 一株牛支原体强毒株及其应用 |
| RU2764220C1 (ru) * | 2020-12-02 | 2022-01-14 | Федеральное государственное бюджетное научное учреждение "Краснодарский научный центр по зоотехнии и ветеринарии" ФГБНУ КНЦЗВ | Способ предупреждения риска заболевания парагриппом-3 у телят |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3634587A (en) * | 1969-11-06 | 1972-01-11 | Ralston Purina Co | Method of immunizing cattle against bovine respiratory disease syndrome |
| BE759425A (fr) * | 1969-11-28 | 1971-05-25 | Mebus Charles A | Vaccins contre la diarrhee du veau, leur preparation et emploi |
| US5593873A (en) | 1986-01-27 | 1997-01-14 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
| US5084269A (en) | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
| ATE60999T1 (de) * | 1986-12-19 | 1991-03-15 | Duphar Int Res | Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension. |
| US6291228B1 (en) * | 1988-08-03 | 2001-09-18 | Vericore Limited | Vaccine |
| GB8818415D0 (en) * | 1988-08-03 | 1988-09-07 | Animal Health Inst | Vaccine |
| MX9301736A (es) | 1992-03-30 | 1994-01-31 | Smithkline Beecham Corp | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. |
| US5951988A (en) * | 1993-03-30 | 1999-09-14 | University Of Saskatchewan | Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods |
| AU688819B2 (en) | 1993-11-05 | 1998-03-19 | Bayer Aktiengesellschaft | Viral vector with bovine viral diarrhea virus (BVDV) antigens |
| BR9507717A (pt) * | 1994-05-10 | 1997-09-23 | American Home Prod | Vacina brsv viva modificada aperfeiçoada |
| US5709865A (en) | 1994-11-10 | 1998-01-20 | Biostar Inc. | Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53) |
| US6001613A (en) | 1996-05-24 | 1999-12-14 | Board Of Regents Of University Of Nebraska | Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid |
| US6060457A (en) | 1996-06-20 | 2000-05-09 | Universite De Montreal | DNA plasmid vaccine for immunization of animals against BVDV |
| BR9803232A (pt) * | 1997-08-26 | 2000-01-11 | Pfizer Prod Inc | Vaicna de neospora. |
| EP1009382B1 (fr) * | 1997-09-05 | 2003-06-18 | GlaxoSmithKline Biologicals S.A. | Emulsions huile-dans-l'eau contenant des saponines |
| UA78180C2 (uk) * | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| EP0924295A3 (fr) * | 1997-12-04 | 2001-05-16 | Pfizer Products Inc. | Gène de dihydrofolate reductase-thymidilate synthase de neospora |
| AU3757199A (en) | 1998-04-24 | 1999-11-16 | Washington University | Chimeras of hepatitis c virus and bovine viral diarrhea virus |
| AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
| JP2006501237A (ja) * | 2002-08-26 | 2006-01-12 | ファイザー・プロダクツ・インク | 家畜の呼吸系と生殖系の感染症に対するワクチン |
| JP5179521B2 (ja) | 2007-03-05 | 2013-04-10 | カディラ・ヘルスケア・リミテッド | ペグ‐インターフェロンアルファ接合体および凍結保護剤としてラフィノースを含む組成物 |
-
2003
- 2003-08-14 JP JP2004530459A patent/JP2006501237A/ja active Pending
- 2003-08-14 OA OA1200500058A patent/OA12915A/en unknown
- 2003-08-14 EP EP03792580A patent/EP1536830A1/fr not_active Ceased
- 2003-08-14 UA UAA200501771A patent/UA94689C2/ru unknown
- 2003-08-14 KR KR1020057003230A patent/KR20050062542A/ko not_active Ceased
- 2003-08-14 EP EP06122758A patent/EP1743652B1/fr not_active Expired - Lifetime
- 2003-08-14 HR HR20090271A patent/HRP20090271A2/xx not_active Application Discontinuation
- 2003-08-14 RS YUP-2005/0177A patent/RS20050177A/sr unknown
- 2003-08-14 NZ NZ538394A patent/NZ538394A/en not_active IP Right Cessation
- 2003-08-14 ME MEP-2009-213A patent/ME00810B/fr unknown
- 2003-08-14 CA CA2496750A patent/CA2496750C/fr not_active Expired - Lifetime
- 2003-08-14 HR HRP20050192AA patent/HRP20050192B1/hr not_active IP Right Cessation
- 2003-08-14 AU AU2003263390A patent/AU2003263390B2/en not_active Expired
- 2003-08-14 MX MXPA05002255A patent/MXPA05002255A/es active IP Right Grant
- 2003-08-14 PL PL375548A patent/PL216541B1/pl unknown
- 2003-08-14 KR KR1020067022893A patent/KR20060116037A/ko not_active Ceased
- 2003-08-14 CN CNB038203162A patent/CN1315534C/zh not_active Expired - Lifetime
- 2003-08-14 BR BR0313806-2A patent/BR0313806A/pt not_active Application Discontinuation
- 2003-08-14 AT AT06122758T patent/ATE533506T1/de active
- 2003-08-14 NZ NZ565206A patent/NZ565206A/en not_active IP Right Cessation
- 2003-08-14 WO PCT/IB2003/003633 patent/WO2004017990A1/fr not_active Ceased
- 2003-08-14 AP AP2005003238A patent/AP2005003238A0/xx unknown
- 2003-08-14 EA EA200500275A patent/EA011578B1/ru not_active IP Right Cessation
- 2003-08-20 TW TW092122872A patent/TWI272105B/zh not_active IP Right Cessation
- 2003-08-22 UY UY27948A patent/UY27948A1/es not_active Application Discontinuation
- 2003-08-22 PE PE2003000857A patent/PE20040420A1/es not_active Application Discontinuation
- 2003-08-25 AR ARP030103054A patent/AR041047A1/es unknown
- 2003-08-25 GT GT200300180A patent/GT200300180A/es unknown
- 2003-08-25 PA PA20038581101A patent/PA8581101A1/es unknown
- 2003-08-26 US US10/647,919 patent/US20040081666A1/en not_active Abandoned
-
2005
- 2005-01-27 IS IS7672A patent/IS7672A/is unknown
- 2005-02-03 NO NO20050603A patent/NO20050603L/no not_active Application Discontinuation
- 2005-02-09 ZA ZA200501171A patent/ZA200501171B/en unknown
- 2005-02-25 MA MA28121A patent/MA27388A1/fr unknown
- 2005-02-25 TN TNP2005000059A patent/TNSN05059A1/fr unknown
-
2007
- 2007-08-30 US US11/897,421 patent/US20070298053A1/en not_active Abandoned
-
2008
- 2008-12-16 AU AU2008258154A patent/AU2008258154B2/en not_active Expired
-
2009
- 2009-05-15 JP JP2009118662A patent/JP2009215309A/ja not_active Withdrawn
-
2010
- 2010-06-22 US US12/820,566 patent/US9662384B2/en active Active
-
2011
- 2011-12-16 JP JP2011275303A patent/JP5785073B2/ja not_active Expired - Lifetime
-
2012
- 2012-12-28 US US13/729,206 patent/US20130129779A1/en not_active Abandoned
-
2015
- 2015-06-03 JP JP2015113008A patent/JP2015172069A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA27388A1 (fr) | Vaccin pour des infections du systeme respiratoire et du systeme reproducteur chez les bovins | |
| RU2005128790A (ru) | Модифицированные живые вакцины, содержащие вирус бычьего герпеса типа 1 (bhv-1(ibr)) и/или вирус бычьей вирусной диареи (bvdv), для беременных и вскармливаемых особей скота | |
| Straub | BHV1 infections: relevance and spread in Europe | |
| TNSN03155A1 (fr) | Vaccination unidose avec mycoplasma hyopneumoniae | |
| KR20090053967A (ko) | 웨스트 나일 백신 | |
| MXPA02012201A (es) | Metodos y composicion para vacunacion oral. | |
| RU94045898A (ru) | Вакцинная композиция, способ стимулирования иммунной системы | |
| BG108496A (en) | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals | |
| MXPA03011924A (es) | Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado. | |
| Pastoret et al. | Veterinary vaccines for animal and public health | |
| Straub | Persistence of infectious bovine rhinotracheitis-infectious pustular vulvovaginitis virus in the respiratory and genital tract of cattle | |
| JP5865839B2 (ja) | 粘膜アジュバント組成物 | |
| US6383741B2 (en) | Method for treatment of canine distemper | |
| DOP2003000699A (es) | Vacunas para enfermedades reproductoras del ganado | |
| RU2292220C1 (ru) | Способ профилактики инфекционного ринотрахеита и парагриппа-3 крупного рогатого скота | |
| Cazella et al. | Effect of levamisole on the humoral immune response against rabies in cattle | |
| Gatewood et al. | Evaluation of type II killed BVD vaccine in the face of type II BVD challenge | |
| O’Connell et al. | The development and testing of a vaccine for the prevention of infectious bovine keratoconjuctivitis | |
| Do Van Dung et al. | Laboratory trials of a new duck plague vaccine produced in chicken embryo fibroblast cell cultures | |
| TH72040A (th) | วิธีสำหรับการป้องกันโรคระบบสืบพันธุ์ของวัวควาย | |
| HU187793B (en) | Process for producing attenuated living virus vaccine against dog-distemper |